Accure Acne
Boulder, US · Founded 2016 · Delaware corporation
Find your way into Accure Acne
Sign up to see every warm intro you have to Accure Acne
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Accure Acne team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Accure develops an FDA-cleared, CE Mark–approved laser system that treats inflammatory acne by selectively targeting overactive sebaceous glands while sparing surrounding skin. The device is designed for dermatologists and acne patients, using a "treat-to-temperature" algorithm intended to work across all skin types.
Founders & leadership
Accure Acne was founded in 2016 by Ed Barbera and Rox Anderson.




Board
Funding
SEC filings, press & company announcements$29.7M disclosed across 5 of 6 rounds · 2016–2023
- Undisclosed amountprivate placement offeringApr 2021 · 2 sourcesSource ↗
▶$21.8MraisedNov 2025 · 106 investors · Other Health CareRule 506(b)
- Samuel E. NavarroDirector
- Karl NichollsExecutive Officer
- Jeffrey O'Donnell, Sr.Director
- Christopher CarltonExecutive Officer, Director
- Edward BarberaDirector
- Offering amount
- $24M
- Amount sold
- $21.8M
- Minimum investment
- $100K
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.5MraisedApr 2022 · 12 investors · Other Health CareRule 506(b)
- Jeffrey O'DonnellDirector
- Karl NichollsExecutive Officer
- A. Edward BarberaDirector
- Christopher CarltonExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $3.5M
- Minimum investment
- $50K
- Finders' fees
- $315K
- Placement agents
- Maxim Group LLC
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$2MraisedOct 2021 · 20 investors · Other Health CareRule 506(c)
- Christopher CarltonExecutive Officer, Director
- Jeffrey O'DonnellDirector
- A. Edward BarberaDirector
- Karl NichollsExecutive Officer
- Offering amount
- $20M
- Amount sold
- $2M
- Minimum investment
- $10K
- Sales commissions
- $160K
- Placement agents
- M Vest LLC, Maxim Group LLC
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06c
▶$2.2MraisedMay 2017 · 13 investors · Other Health CareRule 506(b)
- Craig DrillDirector
- R. Rox AndersonExecutive Officer
- A. Edward BarberaExecutive Officer, Director
- Accure Acne, LLCPromoter
- Christopher CarltonExecutive Officer, Director
- Offering amount
- $2.2M
- Amount sold
- $2.2M
- First sale
- Feb 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$200KraisedFeb 2016 · 3 investors · Other Health CareRule 506(b)
- A. Edward BarberaExecutive Officer, Director
- Paolo SalvadeoDirector
- Christopher CarltonExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $200K
- First sale
- Feb 2016
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 7
Companies working in the same space as Accure Acne.
In the news
Frequently asked questions
- What does Accure Acne do?
- Accure develops an FDA-cleared, CE Mark–approved laser system that treats inflammatory acne by selectively targeting overactive sebaceous glands while sparing surrounding skin. The device is designed for dermatologists and acne patients, using a "treat-to-temperature" algorithm intended to work across all skin types.
- Who founded Accure Acne?
- Accure Acne was founded by Ed Barbera, Rox Anderson in 2016.
- How much funding has Accure Acne raised?
- Accure Acne has disclosed $29.7M raised across 5 of its 6 known rounds.
- Where is Accure Acne headquartered?
- Accure Acne is headquartered in Boulder, US.



